We've deployed or evaluated all three on Australian and New Zealand healthcare networks. Here's where each one actually wins — and where each one quietly fails.
Bland vs Retell vs Vapi for ANZ healthcare: a real comparison
These three are the most-asked-about platforms in the ANZ healthcare voice market right now. They are not interchangeable. Picking the wrong one for your specific PMS, site count and compliance posture is the most common $200k+ mistake we see.
This is the head-to-head we run in every diagnostic, with the headline verdicts pulled out.
Headline verdicts
- Bland: best raw voice quality, weakest compliance posture for AU healthcare out of the box. Wins when you have engineering capacity to wrap it.
- Retell: best developer ergonomics + telephony stack, middle-of-pack on PMS integration depth. Wins for engineering-led clinic groups.
- Vapi: best orchestration and observability, leans on you to bring the model. Wins for groups already standardised on a specific LLM provider.
None of the three is a turnkey AHPRA-aligned medical receptionist. All three need wrapping. The question is who wraps.
Capability (out of 25)
- Bland: 20 — voice realism is genuinely best-in-class in late 2026.
- Retell: 19 — strong, with better turn-taking under interruption.
- Vapi: 18 — depends heavily on which LLM you pair it with.
Adaptability (out of 25)
- Bland: 17 — prompt-and-pray.
- Retell: 22 — proper flow versioning, rollback, observability.
- Vapi: 21 — strong dev surface; flow editor weaker than Retell.
Performance (out of 25)
- Bland: 21 — sub-600ms P50 in our AU benchmarks.
- Retell: 19 — sub-800ms P50, very consistent.
- Vapi: 19 — variable by LLM choice.
Reliability (out of 25)
- Bland: 14 — AU-region hosting requires custom work; compliance docs thin.
- Retell: 18 — AU presence improving; SOC2 in place.
- Vapi: 17 — solid uptime; compliance posture LLM-dependent.
Aggregate (CAPR / 100)
- Bland: 72.
- Retell: 78.
- Vapi: 75.
Weight by your deployment stage — see the CAPR framework post. The ranking shifts.
Who picks which in our 2026 engagements
- Mid-size GP networks (5–20 sites) on Best Practice / MD: Retell wins ~60% of the time.
- Engineering-heavy specialist groups: Bland wins ~40%, Retell ~35%.
- Networks with existing OpenAI / Anthropic commitments: Vapi wins ~40%.
- NZ-only Medtech networks: none of the three is the default — see our NZ-specific evaluation.
The 40–60% who don't fit any of those patterns end up on a fourth vendor — usually PolyAI or Parloa for larger enterprise, or an ANZ-native vendor for tight compliance fits.
If you want the head-to-head scored against your network's specifics, run the shortlist tool.